Investors
Investor Information
Revolo Biotherapeutics is a privately held, venture-funded biotechnology firm engaged in the development of unique and revolutionary therapies. Looking to learn more? Don’t hesitate to contact us.
Events
Upcoming Events
There are no upcoming events at this time.
Past Events
26
Feb
February 26th & 27th 2024 – BIO CEO & Investor Conference
1:1 meetings – New York
29
Aug
Presentation – ‘1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) and Allergic Disease – Virtual
30
May
Presentation – Targeting Tissue Resident Tregs in Autoimmune Disease Revolutionary Approach to Resetting the Immune System for Long-Term Autoimmune Disease Remission – Boston